Related Experiment Video
Updated: Mar 13, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
14.7K
IGF1R signalling and its inhibition.
1Cancer Research UK Laboratories, Weatherall Institute of Molecular Medicine, Oxford OX3 9DS, UK.
Endocrine-Related Cancer
|January 30, 2007
Summary
The type 1 IGF receptor (IGF1R) is a promising anti-cancer target. Blocking IGF signalling shows potential in preclinical and clinical trials, offering new therapeutic strategies for various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase.
- IGF1R is overexpressed in tumors and influences proliferation, apoptosis, invasion, and metastasis.
- IGF signalling impacts hypoxia, protease secretion, and cell motility, making IGF1R a key anti-cancer target.
Purpose of the Study:
- To review the effects of IGF1R activation in tumor cells.
- To outline strategies for blocking IGF signalling as anti-cancer therapeutics.
- To discuss the development and challenges of IGF1R inhibitors.
Main Methods:
- Review of existing literature on IGF1R signalling and therapeutic strategies.
- Analysis of preclinical data and early clinical trials of IGF1R inhibitors and antibodies.
- Exploration of antisense and siRNA-mediated IGF1R downregulation.
Main Results:
- Selective IGF1R inhibitors and antibodies show promise in preclinical cancer models.
- Several IGF1R-targeting agents are in early clinical trials.
- Antisense and siRNA approaches offer potential as research tools and future therapeutics.
Conclusions:
- IGF1R blockade is a developing anti-cancer strategy with potential clinical benefits.
- Challenges include achieving specificity due to homology with the insulin receptor.
- Further research is needed to identify biomarkers for sensitivity and optimize combination therapies.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.8K
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
8.7K
Related Concept Videos
01:16TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
01:20The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
01:19Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
01:22Amplifying Signals via Enzymatic Cascade
19.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
02:33Hedgehog Signaling Pathway
10.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.3K
01:24Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K